These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11222361)

  • 1. Serum nm23-H1 protein as a prognostic factor in aggressive non-Hodgkin lymphoma.
    Niitsu N; Okabe-Kado J; Okamoto M; Takagi T; Yoshida T; Aoki S; Hirano M; Honma Y
    Blood; 2001 Mar; 97(5):1202-10. PubMed ID: 11222361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum nm23-H1 protein as a prognostic factor for indolent non-Hodgkin's lymphoma.
    Niitsu N; Okamoto M; Okabe-Kado J; Takagi T; Yoshida T; Aoki S; Honma Y; Hirano M
    Leukemia; 2001 May; 15(5):832-9. PubMed ID: 11368446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic implications of the differentiation inhibitory factor nm23-H1 protein in the plasma of aggressive non-Hodgkin's lymphoma.
    Niitsu N; Okabe-Kado J; Kasukabe T; Yamamoto-Yamaguchi Y; Umeda M; Honma Y
    Blood; 1999 Nov; 94(10):3541-50. PubMed ID: 10552965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum nm23-H1 protein as a prognostic factor in hematological malignancies.
    Okabe-Kado J
    Leuk Lymphoma; 2002 Apr; 43(4):859-67. PubMed ID: 12153176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The prognostic relation of nm23-H1/NDPK-A with leukemia and lymphoma].
    Li HY; Liu JS; Wang YF
    Sheng Li Ke Xue Jin Zhan; 2003 Jan; 34(1):74-7. PubMed ID: 12778818
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical significance of nm23-H1 proteins expressed on cell surface in non-Hodgkin's lymphoma.
    Niitsu N; Honma Y; Iijima K; Takagi T; Higashihara M; Sawada U; Okabe-Kado J
    Leukemia; 2003 Jan; 17(1):196-202. PubMed ID: 12529678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum levels of mm23-H1 protein and their clinical implications in malignant lymphoma].
    Niitsu N
    Rinsho Ketsueki; 2001 Dec; 42(12):1155-61. PubMed ID: 11828717
    [No Abstract]   [Full Text] [Related]  

  • 8. Expression of nm23-H1 is associated with poor prognosis in peripheral T-cell lymphoma.
    Niitsu N; Nakamine H; Okamoto M; Akamatsu H; Honma Y; Higashihara M; Okabe-Kado J; Hirano M;
    Br J Haematol; 2003 Nov; 123(4):621-30. PubMed ID: 14616965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of the differentiation inhibitory factor nm23-H1 protein and their clinical implications in acute myelogenous leukemia.
    Niitsu N; Okabe-Kado J; Nakayama M; Wakimoto N; Sakashita A; Maseki N; Motoyoshi K; Umeda M; Honma Y
    Blood; 2000 Aug; 96(3):1080-6. PubMed ID: 10910925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability of nm23-H1/NDPK-A expression in human lymphomas and its relation to tumour aggressiveness.
    Aryee DN; Simonitsch I; Mosberger I; Kos K; Mann G; Schlögl E; Pötschger U; Gadner H; Radaszkiewicz T; Kovar H
    Br J Cancer; 1996 Dec; 74(11):1693-8. PubMed ID: 8956779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of intracytoplasmic nm23-H1 expression in diffuse large B-cell lymphoma.
    Niitsu N; Nakamine H; Okamoto M; Akamatsu H; Higashihara M; Honma Y; Okabe-Kado J; Hirano M
    Clin Cancer Res; 2004 Apr; 10(7):2482-90. PubMed ID: 15073128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated plasma level of differentiation inhibitory factor nm23-H1 protein correlates with risk factors for myelodysplastic syndrome.
    Ito Y; Okabe-Kado J; Honma Y; Iwase O; Shimamoto T; Ohyashiki JH; Ohyashiki K
    Leukemia; 2002 Feb; 16(2):165-9. PubMed ID: 11840281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of the nm23-H1 protein and their clinical implication in extranodal NK/T-cell lymphoma.
    Niitsu N; Okamoto M; Honma Y; Nakamine H; Tamaru JI; Nakamura S; Yoshino T; Higashihara M; Hirano M; Okabe-Kado J;
    Leukemia; 2003 May; 17(5):987-90. PubMed ID: 12750720
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical significance of biological prognostic factors in non-Hodgkin lymphoma: analysis of serum and cell surface nm 23-H1 protein].
    Niitsu N
    Rinsho Ketsueki; 2003 Apr; 44(4):211-8. PubMed ID: 12784653
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined analysis of differentiation inhibitory factor nm23-H1 and nm23-H2 as prognostic factors in acute myeloid leukaemia.
    Wakimoto N; Yokoyama A; Okabe-Kado J; Nagata N; Motoyoshi K; Honma Y
    Br J Cancer; 1998 Jun; 77(12):2298-303. PubMed ID: 9649149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. nm23-H1 expression in non-Hodgkin and Hodgkin lymphomas.
    Bircan S; Inamdar KV; Rassidakis GZ; Medeiros LJ
    Appl Immunohistochem Mol Morphol; 2008 May; 16(3):207-14. PubMed ID: 18301251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation by multivariate analysis of the differentiation inhibitory factor nm23 as a prognostic factor in acute myelogenous leukemia and application to other hematologic malignancies.
    Yokoyama A; Okabe-Kado J; Wakimoto N; Kobayashi H; Sakashita A; Maseki N; Nakamaki T; Hino Ki; Tomoyasu S; Tsuruoka N; Motoyoshi K; Nagata N; Honma Y
    Blood; 1998 Mar; 91(6):1845-51. PubMed ID: 9490665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of nm23 protein expression in renal cell carcinomas.
    Nakagawa Y; Tsumatani K; Kurumatani N; Cho M; Kitahori Y; Konishi N; Ozono S; Okajima E; Hirao Y; Hiasa Y
    Oncology; 1998; 55(4):370-6. PubMed ID: 9663430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin.
    Heimann R; Lan F; McBride R; Hellman S
    Cancer Res; 2000 Jan; 60(2):298-304. PubMed ID: 10667580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated nm23 protein expression is correlated with diminished progression-free survival in patients with epithelial ovarian carcinoma.
    Srivatsa PJ; Cliby WA; Keeney GL; Dodson MK; Suman VJ; Roche PC; Podratz KC
    Gynecol Oncol; 1996 Mar; 60(3):363-72. PubMed ID: 8774640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.